When pioneering eye surgeon Sir Harold Ridley invented a groundbreaking intraocular lens to treat cataracts back in 1949, he turned to ophthalmic manufacturer Rayner to make his vision a reality. Since then, Rayner’s products have continued to improve the sight and quality of life of many millions of people around the globe.
Taking the vision forward
From its state-of-the-art manufacturing facilities in the UK, Rayner provides innovative and clinically superior ophthalmic products to more than 2.4 million patients a year in over 80 countries through its subsidiaries and distribution network. It has a strong reputation for R&D excellence and a broad portfolio across the patient pathway, as well as a digital platform that gives surgeons real-time data on patient outcomes.
In June 2021, Rayner’s ambitious management team joined forces with CVC to accelerate international expansion of the business. CVC’s long-term relationships with the business’s management and its global network and knowledge of the sector, enabled CVC to attain preferred bidder status in a limited auction process. To date, the partnership has succeeded in:
- Launching 13 new products over the last 4 years through R&D investment
- Boosting Rayner’s international presence in Australia, Belgium, France and India.
- Acquiring Omidria™ to expand its surgical consumables offering in the USA and Europe, and HASA Optix to add recyclable instruments to the portfolio.
- Integrating ESG targets such as energy efficiency, emissions reduction and efficient water usage into financial incentives and investing in solutions to reduce plastic usage in product packaging using a CVC People and Planet Grant.
With its extensive healthcare experience, CVC understands our business and supports our ambition to become an international ophthalmology leader.
Tim Clover CEO, Rayner
Enabling successful patient outcomes across society
Rayner and CVC continue to consolidate the business’s leading position in a robust and growing sector underpinned by an ageing population, increased penetration of ocular surgeries across age categories and geographies, and a growing patient focus on improved visual outcomes.
To support those less able to access specialist care, Rayner works with the IMPACT Foundation, which aims to prevent disability and promote independent, sustainable living. In Bangladesh, Rayner has enabled some of the world’s poorest people to have their sight restored with first class treatment and products.